Related Experiment Video

Updated: Oct 7, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K

Oncolytic Viruses and Cancer, Do You Know the Main Mechanism?

Wesam Kooti1, Hadi Esmaeili Gouvarchin Ghaleh1, Mahdieh Farzanehpour1

  • 1Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Frontiers in Oncology
|January 10, 2022
PubMed

Insights

Oncolytic viruses (OVs) show great promise for cancer treatment by selectively killing tumor cells and stimulating anti-cancer immunity. This review evaluates OVs and their mechanisms for effective cancer therapy.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Cancer remains a significant global health threat with increasing incidence.
  • Viruses are emerging as potent tools in novel cancer treatment strategies.
  • Oncolytic viruses (OVs) offer a promising therapeutic avenue for malignant tumors.

Purpose of the Study:

  • To review and evaluate the potential of oncolytic viruses (OVs) in cancer therapy.
  • To elucidate the precise mechanisms by which OVs exert their anti-cancer effects.
  • To assess the role of OVs in selective tumor targeting and immune system modulation.

Main Methods:

  • Literature review of studies on oncolytic viruses and their application in cancer treatment.
  • Analysis of the mechanisms of action, including viral replication, cell lysis, and immune response induction.
  • Evaluation of OV-mediated tumor targeting and cancer cell killing strategies.

Main Results:

  • OVs demonstrate selective replication in cancer cells, leading to tumor cell lysis.
  • OVs can induce specific anti-tumor immune responses, enhancing therapeutic efficacy.
  • Targeting tumors and understanding OV mechanisms are critical for successful cancer therapy.

Conclusions:

  • Oncolytic viruses represent a promising and evolving approach to cancer treatment.
  • Further research into OV mechanisms can optimize their use in clinical settings.
  • OVs hold significant potential for improving outcomes in malignant tumor therapy.
Keywords:
cancer immunotherapycancer vaccineimmune checkpointoncolytic virustargeted treatment

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.2K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

12.8K

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
3.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
719
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K